Virology Research Today is a free monthly online journal that collates and summarizes the latest research about Virology, including details on viruses, pathology, classification, definitions.

Volume 3 (2007), Issue 3 (March)

1. Adherence and plasma drug concentrations are predictors of confirmed virologic response after 24-week salvage highly active antiretroviral therapy.
   AIDS Patient Care STDS, 21(2): 92-9. [Abstract] [Full-text]
2. Characterization of alpha-Defensins Plasma Levels in Macaca Fascicularis and Correlations with Virological Parameters during SHIV89.6P(cy11) Experimental Infection.
   AIDS Res Hum Retroviruses, 23(2): 287-296. [Abstract] [Full-text]
3. The Rate of Epidemiological And Virological Changes during The Transition from Nascent to Concentrated HIV Epidemic Stage in The Former Soviet Union Countries.
   AIDS Res Hum Retroviruses, 23(2): 183-92. [Abstract] [Full-text]
4. Sustained virological response to interferon-alpha is associated with improved outcome in HCV-related cirrhosis: a retrospective study.
   Hepatology, 45(3): 579-87. [Abstract] [Full-text]
5. Early virologic rebound in a pilot trial of ritonavir-boosted atazanavir as maintenance monotherapy.
   J Acquir Immune Defic Syndr, 44(4): 417-22. [Abstract] [Full-text]
6. Superior virological response to boosted protease inhibitor-based highly active antiretroviral therapy in an observational treatment programme.
   HIV Med, 8(2): 80-5. [Abstract] [Full-text]
7. Association of Gag cleavage sites to protease mutations and to virological response in HIV-1 treated patients.
   J Infect, 54(4): 367-74. [Abstract] [Full-text]
8. Progressive multifocal leukoencephalopathy in a haploidentical stem cell transplant recipient: a clinical, neuroradiological and virological response after treatment with risperidone.
   Antiviral Res, 74(2): 156-8. [Abstract] [Full-text]
9. The virologic, immunologic, and clinical effects of interleukin 2 with potent antiretroviral therapy in patients with moderately advanced human immunodeficiency virus infection: a randomized controlled clinical trial--AIDS Clinical Trials Group 328.
   Arch Intern Med, 167(6): 597-605. [Abstract] [Full-text]

© 2005-2008 Virology Research Today. All Rights Reserved.